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Abstract
Background: Conversion of linoleic acid (LA) and alpha-linolenic acid (ALA) to their higher chain
homologues in humans depends on the ratio of ingested n6 and n3 fatty acids.
Design and methods: In order to determine the most effective ratio with regard to the
conversion of ALA to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), human
hepatoma cells were incubated with varying ratios of [13C] labeled linoleic acid ([13C]LA)- and
alpha-linolenic acid ([13C]ALA)-methylesters. Regulative cellular signal transduction pathways
involved were studied by determinations of transcript levels of the genes encoding delta-5
desaturase (D5D) and delta-6 desaturase (D6D), peroxisome proliferator-activated receptor alpha
(PPARα) and sterol regulatory element binding protein 1c (SREBP-1c). Mitogen-activated protein
kinase kinase 1 (MEK1) and mitogen-activated protein kinase kinase kinase 1 (MEKK1) were also
examined.
Results: Maximum conversion was observed in cells incubated with the mixture of [13C]LA/
[13C]ALA at a ratio of 1:1, where 0.7% and 17% of the recovered [13C]ALA was converted to DHA
and EPA, respectively. Furthermore, differential regulation of enzymes involved in the conversion
at the transcript level, dependent on the ratio of administered n6 to n3 fatty acids in human
hepatocytes was demonstrated.
Conclusion: Formation of EPA and DHA was highest at an administered LA/ALA ratio of 1:1,
although gene expression of PPARα, SREBP-1c and D5D involved in ALA elongation were higher
in the presence of ALA solely. Also, our findings suggest that a diet-induced enhancement of the
cell membrane content of highly unsaturated fatty acids is only possible up to a certain level.
Introduction
Long chain polyunsaturated fatty acids (LCPUFA) of the
n6 and n3 families as well as their precursors are essential
dietary components for mammalian species [1]. LCPUFAs
appear to be a necessary integral part of membrane phos-
pholipids for optimal biological function particularly in
specialized cells and tissues such as brain, retina, testes,
heart, liver and kidneys [2]. The constitutive properties of
PUFA in biological membranes generally are regarded in
terms of their contributions to the fluidity or integrity of
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membrane bilayer structures [3,4]. Increasing evidence for
competitive interactions between PUFA of the n6 and n3
fatty acid families at the level of formation and action of
eicosanoids, thromboxanes, prostacyclins, prostagland-
ins, and leukotrienes appear to relate directly to potential
benefits attributed to an eligible dietary balance of n3 and
n6 fatty acids [5]. Within the common Western diet, ALA
represents the quantitatively dominant fatty acid of the n3
series. Daily ALA uptake averages 1.5 g, whereas the aver-
age daily uptake of the corresponding n6 fatty acid LA is
about 10 times higher [6].
With this 10:1 ratio of dietary n6 to n3 LCPUFA, the for-
mation of pro-inflammatory/aggregatory eicosanoids
from LA is favored over those from n3 fatty acids showing
anti-inflammatory/aggregatory effects. Controlling the
synthesis of n3 LCPUFA, such as EPA and DHA from ALA,
and the respective eicosanoids by consumption of the
optimized ratio of n6 to n3 LCPUFA is, therefore, of par-
ticular nutritional interest.
In addition, LCPUFA and their derivatives are of increas-
ing interest as modulators of gene expression. They are
reported for example to be ligands of the nuclear tran-
scription factors peroxisome proliferator-activated recep-
tors (PPARs) [7] and suppressors of sterol regulatory
element binding proteins (SREBP) [8]. Regulating the
degradation of fatty acids by mitochondrial as well as by
peroxisomal and microsomal fatty acid oxidation, PPARα
plays a central role in fatty acid homeostasis (reviewed in
Ref. [9]). SREBP-1 isoforms on the other hand are more
active in regulating hepatic synthesis of fatty acids [10].
Both, PPARs and SREBPs are reported to regulate expres-
sion of delta-5-desaturase (D5D) and delta-6-desaturase
(D6D) [11,12]. SREBPs as well as PPARs are, in addition
to their ligand-induced regulation activity, substrates for
several kinases such as mitogen-activated protein kinases
(MAPK) [13,14]. Furthermore, ligands for the PPAR recep-
tor family such as the essential fatty acids linoleic (LA,
18:2-n6) and alpha-linolenic (ALA, 18:3-n3) acid have
recently been shown to induce MAPK phosphorylation
[15,16].
LA and ALA are converted to their longer chain homo-
logues by a combination of subsequent reactions, involv-
ing Δ6 desaturation, elongation and Δ5 desaturation. Since
members of the n6 and n3 families compete for the corre-
sponding enzyme systems [17-19], the conversion of e.g.
LA or ALA into their longer chain homologues is signifi-
cantly influenced by the composition of dietary fats
[20,21]. In this context, whether incorporation of n3 fatty
acids into cell membranes and their bioconversion into
higher homologues depends on either the absolute
amount of dietary n3 fatty acids or rather on the ratio of
ingested n6/n3 fatty acids has been controversially dis-
cussed.
In a human intervention trial by Liou et al. 2007 [22],
diets containing LA/ALA ratios of 10:1 or 4:1 were admin-
istered to healthy men. The different LA/ALA ratios were
adjusted by altering the LA content in the diet (high-LA or
low-LA), while the ALA content was maintained constant.
As a result, the ALA as well as the EPA concentration of
plasma phospholipids in the low-LA group (4:1 ratio)
increased compared to the high-LA group (LA/ALA ratio
10:1), although the ALA amount administered was equal
in both groups. This result clearly shows that lowering die-
tary LA intake increases EPA in plasma phospholipids,
indicating the rate of conversion of ALA to EPA being
dependent on the ratio of n3/n6 fatty acids. In contrast to
that, Goyens et al. 2006 [23] postulated that bioconver-
sion of ALA in humans is influenced by the absolute
amounts of dietary ALA and LA and not by their ratio. In
this study, healthy volunteers were randomly divided into
3 experimental groups: 1) high ratio LA group (LA/ALA =
19:1), 2) low ratio low-LA group (LA/ALA = 7:1) and 3)
low ratio high-ALA group (LA/ALA = 7:1). Within the lat-
ter two groups, the 7:1 ratio was adjusted by lowering the
LA content or increasing the ALA content of the diet
respectively, compared to the diet of the high ratio LA
group. In addition to the diet, multiple tracer bolus doses
of [U-13C]ALA were administered to the subjects to esti-
mate ALA conversion by compartmental modeling. Calcu-
lations derived from this study confirmed the hypothesis
that conversion of ALA is rather influenced by the abso-
lute amounts of dietary ALA and LA than by the ratio of
ALA/LA. However, analyses of plasma phospholipid fatty
acid composition at the end of this dietary intervention
showed that concentrations of ALA and EPA within the
two low ratio groups (LA/ALA = 7:1) were significantly
higher compared to the high ratio LA group. However,
there was no difference between the ALA and EPA plasma
phospholipid contents of the two low ratio groups. These
results, on the other hand, support the hypothesis that
incorporation and bioconversion of ALA are rather influ-
enced by the ratio of dietary LA/ALA. However, no final
conclusion can be drawn from the data available concern-
ing the question, whether the conversion is rather
dependent on the absolute amount of fatty acids than on
the ratio of n6/n3 fatty acids. Furthermore, quantitative
data on the conversion of n3 LCPUFA as affected by the
ratio of n6 to n3 fatty acids are scarce. Therefore, the
objective of our study was to quantify the conversion of
[13C]alpha-linolenic acid to eicosapentaenoic acid and
docosahexaenoic acid in the presence of varying n6/n3
fatty acid ratios in the hepatoma cell line HepG2. In addi-
tion, the transcript levels of genes encoding for enzymes
involved in the fatty acid conversion were also examinedNutrition & Metabolism 2009, 6:8 http://www.nutritionandmetabolism.com/content/6/1/8
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HepG2 cells were obtained from Dept. of Human and
Animal Cell Cultures (DSMZ), Braunschweig, Germany.
The cells were grown in T-75 cell culture flasks (Sarstedt,
Germany) in 15 ml Dulbecco's modified Eagle's medium
(DMEM) containing 20% fetal calf serum (FCS), 2%
glutamine and 2% penicillin/streptomycin solution
(Sigma). Cells were maintained at 37°C in a humidified
atmosphere of 95% air/5% CO2 and were subcultured
every 7 days. For the experiments carried out, cells were
transferred to T-25 cell culture flasks (Sarstedt, Germany)
at a density of 5 × 106 cells. After 24 hrs, the medium was
replaced with 8 ml DMEM without FCS. After another 24
hrs, mixtures of [13C] labeled LA/ALA (suspended by son-
ication in sterile bovine serum albumin, Fraction V,
Sigma) were added to give a final fatty acid concentration
of 100 μM. Ratios of LA/ALA were 9:1, 4:1, 1:1, 1:0 and
0:1. Cells were incubated for 24 hrs at 37°C and the expo-
sure in each case was carried out as a quadruplicate deter-
mination. At the end of the exposure process, cells were
harvested by adding 1 ml of accutase (Sigma). The cell cul-
ture medium was collected separately for determination
of [13C]LA and [13C]ALA content. After harvesting, cells
were washed with 2 ml of FCS free DMEM and centrifuged
at 500 × g. After adding 1 ml of sodium chloride solution
(0.9%; w/v) to the cell pellet, cells were stored at -75°C.
Lipid extraction and fatty acid analysis
Lipids were extracted from the cells by a modified Folch
extraction [24], with the addition of 100 μl of internal
standard (1 mg/ml of tetracosanoic acid and 3 mg/ml
heptadecanoic acid, dissolved in dichlormethane:metha-
nol, 2:1, v:v) to each sample. The extraction procedure
was followed by saponification and methylation of the
fatty acids according to an AOAC method [25]. Fatty acid
composition was determined via HRGC-CI/-MS [26].
Determination of absolute contents of the several fatty
acids was carried out by external calibration.
Cell culture experiments
For gene expression experiments, cells were pretreated as
described above. Within the scope of kinetic experiments,
cells were exposed to 100 μM pure ALA-methylester for 3,
6, 12 and 24 hrs, respectively, to find out the point of
maximal gene expression of D5D, D6D, PPARα, SREBP-
1c, MEK1 and MEKK1 via real time PCR (MX 3000P, Strat-
agene).
For dose response experiments, HepG2 cells were exposed
to mixtures of LA-/ALA-methylester at ratios of 4:1, 1:1,
1:0 and 0:1. Here, the 9:1 ratio was not tested since there
was no difference between the 9:1 and the 4:1 mixture
with regard to [13C]ALA-incorporation and the formation
of [13C]EPA and [13C]DHA.
Depending on the results of kinetic experiments, expres-
sion of the several aforesaid target genes was determined
after 3, 6 or 12 hrs. After incubation, cells were harvested
as described earlier and RNA was isolated with RNeasy
mini kit®  (Qiagen). cDNA was synthesizd using
StrataSkript® cDNA synthesis kit (Stratagene) according to
manufacturer's instructions. For amplification of gene
transcripts during the realtime PCR reactions, validated
primer assays from Qiagen were used according the man-
ufacturer's protocol. Human transferrin receptor was cho-
sen as house keeping gene. Brilliant®  SYBR®  Green
(Stratagene) was used for detection of amplified gene
products during the PCR reaction.
Statistical analysis
Data were analyzed with SPSS for WINDOWS 14.0 (SPSS
Inc, Chicago, IL). Data were tested for normal distribution
using the Kolmogorov-Smirnov test. All data are expressed
as mean ± SEM. Statistical significance of results was
assessed using two-tailed Student's t-test for non-paired
samples. A p-value of less than 0.05 was considered statis-
tically significant.
Results
Experiments with non-labeled fatty acids to identify 
experimental conditions of putative maximum elongation 
rates
The time-dependent effects regarding the incorporation of
ALA-methylester and a resulting increase in EPA and DHA
concentrations were investigated. For this purpose, Hep-
G2 cells were incubated with 100 μM ALA-methylester
over periods of 0 h, 6 h, 12 h, 24 h, 48 h and 72 h. Subse-
quently, dose response experiments were performed with
ALA-methylester at concentrations of 10 μM, 100 μM and
1000 μM and an exposure time of 24 hrs. Highest incor-
poration of ALA methylester and the most pronounced
increase in EPA and DHA were analyzed after a 24 h incu-
bation period in the presence of 100 μM ALA-methylester
(data not shown).
Experiments with labeled fatty acids to investigate ALA 
elongation and desaturation
HepG2 cells were exposed to varying mixtures of [13C]
labeled ALA and LA. Whereas the total concentration of
LCPUFA administered was the same for all experiments
(100 μM), the ratios of [13C]ALA to [13C]LA tested were
0:1, 1:1, 4:1, 9:1 and 1:0.
Total recoveries of [13C]LA and [13C]ALA as well as the
amounts of [13C]EPA, [13C]DHA and [13C]AA at the differ-
ent ratios of [13C]LA and [13C]ALA are given in Table 1.Nutrition & Metabolism 2009, 6:8 http://www.nutritionandmetabolism.com/content/6/1/8
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Cellular recovery of [13C]LA was highest (75.3 μmol or
74.6 μmol) in cells incubated with the mixture of a n6 to
n3 ratio of 9:1 or with pure LA, respectively. Of the admin-
istered amount of [13C]LA, the highest percentage recov-
ery as [13C]LA was detected in cells which were exposed to
the mixtures of 4:1 (83%) or 9:1 (84%), respectively,
whereas in cells exposed to the 1:1 mixture or to pure LA,
merely 75% of the [13C]LA applied to the cells were recov-
ered. The amount of [13C]AA quantified was highest in
cells exposed to the mixtures at n6 to n3 ratios of 4:1 (5.7
μmol) or 9:1 (6.3 μmol), respectively (Table 1 and 2).
Of the recovered cellular amounts of [13C]LA, the amount
of [13C]AA quantified was equally high in those cells
which were incubated with [13C]LA/[13C]ALA at ratios of
1:1, 4:1 and 9:1, whereas treatment of the cells with pure
[13C]LA resulted in a significantly lower content of
[13C]AA (Fig. 1A). Total cellular recovery of [13C]LA rang-
ing between 85 and 96% (data not shown) was calculated
from the sum of quantified [13C]AA and [13C]LA in the
cell culture medium and in the cells.
As well as incorporation of [13C]LA, effective incorpora-
tion of [13C]ALA increased with escalating amounts of
administered [13C]ALA (Table 1). Percentage cellular
recovery of [13C]ALA, relating to its administered amount,
was 65% in cells which were exposed to pure ALA or to the
mixture at a ratio of 1:1, and 69% in cells incubated with
the 9:1 mixture. The highest recovery of [13C]ALA (82%)
was documented in cells which were exposed o the 4:1
fatty acid mixture of [13C]LA and [13C]ALA.
The content of [13C]EPA also increased with ascending
amounts of administered [13C]ALA and was the highest in
cells exposed to pure [13C]ALA (10.8 μmol). On the other
hand regarding cells which were exposed to mixtures of
[13C]LA/[13C]ALA, the amount of [13C]DHA was highest
(0.48 μmol) at a ratio of 1:1.
Of the recovered quantity of [13C]ALA, the content of
[13C]EPA was highest in cells incubated with pure
[13C]ALA and a mixture of [13C]LA/[13C]ALA at a ratio of
1:1 (Fig. 1B). In those cells, the amount of [13C]EPA in
each case was 17% of the recovered quantity of [13C]ALA.
Moreover, the highest percentage amount of DHA (0.7%
of recovered [13C]ALA) was formed in cells incubated with
[13C]LA/[13C]ALA at a ratio of 1:1.
Total recoveries of [13C]ALA (as a sum of cellular recov-
ered [13C]ALA and [13C]EPA or [13C]DHA, respectively
and the [13C]ALA remaining in the cell culture medium)
ranged between 86% (0:1 and 1:1 mixture) and 97% (5:1
mixture) (data not shown).
Gene expression experiments
Kinetic experiments
Since enhanced amounts of [13C]EPA and [13C]DHA were
detected in HepG2 cells after incubation with [13C]ALA,
we wanted to investigate whether this conversion is asso-
Table 1: Recovery of [13C]LA or [13C]ALA after exposure of HepG2 cells to [13C]LA-/[13C]ALA-methylester at ratios of 0:1, 1:1, 4:1, 
9:1 and 1:0 for 24 hours. 1not detected, LOD: 0.13 ng/μl.
LA/ALA 0:1 LA/ALA 1:1 LA/ALA 4:1 LA/ALA 9:1 LA/ALA 1:0
13C LA administered [μmol] 0 50 80 90 100
cell culture medium [μmol] n.d.1 7.1 ± 0.75 3.8 ± 0.35 4.5 ± 0.14 7.0 ± 0.37
cells [μmol] n.d.1 37.6 ± 1.96 66.0 ± 2.51 75.3 ± 1.80 74.6 ± 2.97
percent administered [%] - 83 84 75 75
13C ALA administered [μmol] 100 50 20 10 0
cell culture medium [μmol] 9.0 ± 1.2 4.7 ± 0.27 1.3 ± 0.11 2.1 ± 0.11 n.d.1
cells [μmol] 65.3 ± 3.90 32.6 ± 2.15 16.41 ± 0.31 6.90 ± 0.17 n.d.1
Percent administered [%] 65 65 82 69 -
Table 2: Quantification of [13C]AA, [13C]EPA and [13C]DHA after exposure of HepG2 cells to [13C] LA-/[13C]ALA-methylester at 
ratios of 0:1, 1:1, 4:1, 9:1 and 1:0 for 24 hours.
LA/ALA 0:1 LA/ALA 1:1 LA/ALA 4:1 LA/ALA 9:1 LA/ALA 1:0 
13C LA administered [μmol] - 50 80 90 100
13C AA [μmol] - 3.4 ± 0.04 5.7 ± 0.32 6.3 ± 0.21 3.3 ± 0.27
13C ALA administered [μmol] 100 50 20 10 -
13C EPA [μmol] 10.8 ± 0.51 5.7 ± 0.19 1.5 ± 0.05 1.4 ± 0.04 -
13C DHA [μmol] 0.18 ± 0.02 0.48 ± 0.01 0.11 ± 0.01 0.04 ± 0.004 -Nutrition & Metabolism 2009, 6:8 http://www.nutritionandmetabolism.com/content/6/1/8
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Percentage conversion of [13C]LA and [13C]ALA into [13C]AA and [13C]EPA/[13C] after exposure of HepG2 cells to [13C]LA-/ [13C]ALA-methylester at ratios of 0:1, 1:1, 4:1, 9:1 and 1:0 Figure 1
Percentage conversion of [13C]LA and [13C]ALA into [13C]AA and [13C]EPA/[13C] after exposure of HepG2 
cells to [13C]LA-/[13C]ALA-methylester at ratios of 0:1, 1:1, 4:1, 9:1 and 1:0. Data are expressed as mean ± SEM. 
Bars without a common letter are statistically significant different (*: p ≤ 0.05).Nutrition & Metabolism 2009, 6:8 http://www.nutritionandmetabolism.com/content/6/1/8
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ciated with enhanced expression of genes encoding for
proteins related to lipid metabolism. Therefore, HepG2
cells were incubated with 100 μM of ALA methylester for
3, 6, 12 and 24 hrs and the transcript levels of the genes
encoding for D5D, D6D, PPARα, SREBP-1c, MEKK1 and
MEK1 were determined via Real-time-PCR (Fig. 2). Maxi-
mum mRNA levels of the D5D and the D6D gene were
detected after 3 and 6 hrs of cells' treatment. The mRNA
levels of the genes encoding for nuclear receptor proteins
PPARα and SREBP-1c were highest after an incubation
period of 3 hrs. The quantity of mRNA of the kinases
MEKK1-gene and MEK1-gene was the highest in those
cells which were incubated with ALA-methylester for 3
and 12 hrs, respectively.
Dose response experiments
The kinetic experiments revealed that after 3 hrs of incu-
bating HepG2 cells with 100 μM ALA methylester, the
transcript levels of the investigated genes reached their
maximum. At this point in time, a dose-response experi-
ment was carried out in order to investigate the influence
of different mixtures of LA/ALA on the mRNA levels of the
genes encoding for D5D, D6D, PPARα, SREBP-1c, MEKK1
and MEK1 (Fig. 3).
Compared to non-exposed control cells, the transcript
level of the MEKK1 gene was significantly increased in any
of the experiments, with incubation of the cells with pure
LA and the 4:1 mixture of LA-/ALA-methylester caused the
most considerable effects. In contrast, the transcript level
of the MEK1 gene was mainly affected by ALA and not by
LA. With respect to the experiments in which HepG2 cells
were exposed to pure ALA-methylester, an incubation of
the cells with the 1:1 and 4:1 mixture of LA-/ALA-methyl-
ester induced a significant increase (up to 35%) of the
mRNA level of the gene encoding for MEK1.
Transcript levels of genes encoding for PPARα and D5D,
respectively, were only increased after exposure of HepG2
cells to pure ALA-methylester. Compared to non-exposed
cells, mRNA levels of these genes were about 30–50%
higher in cells that were incubated with pure ALA-methyl-
ester.
As well as PPARα and D5D, the transcript level of the
SREBP 1c-gene was significantly increased after incuba-
tion with pure ALA-methylester. The relative mRNA level
was about 75% higher than in non-exposed cells. Further-
more, an exposure of HepG2 cells to pure LA-methylester
and the 1:1 mixture of LA-/ALA-methylester, respectively,
caused a significant increase in SREBP-1c gene transcript
levels of up to 30%.
Discussion
In the here presented study, a human hepatoma cell line
(HepG2) was used as a model system to investigate the
impact of varying ratios of n6/n3 fatty acids on the con-
version of alpha-linolenic acid to eicosapentaenoic acid
and docosahexaenoic acid. After exposure of HepG2 cells
to different ratios of [13C] labeled 18:2-n6 and 18:3-n3,
those fatty acids were quantified in the cell matrix. Fur-
thermore, conversion to the corresponding homologues
was demonstrated. At this, rates of incorporation as well
as the extent of conversion differed depending on the
ratio of administered fatty acids.
Incorporation of [13C]LA and [13C]ALA in hepatocytes
Effective incorporated quantities of [13C]ALA as well as
[13C]LA increased with increasing administered amounts
of these fatty acids. Percentage quantities of cellular recov-
ered [13C]LA or [13C]ALA, relating to the administered
amount, however were lower in cells exposed to 100 μM
of a single fatty acid ([13C]LA or [13C]ALA) than in cells
exposed to mixtures of [13C]LA and [13C]ALA. We assume
that these findings may result from a limited ability of the
cells to incorporate PUFAs beyond a certain level.
A study of Robinson et al. [27] confirms this hypothesis.
In this study, the modulating effect of dietary fish oil and
of n3 fatty acid methylesters on spleen phospholipid fatty
acid composition was investigated. Female NZB/W mice
were fed diets containing 3.6 or 10% of EPA or DHA ethyl
ester (EPA-E, DHA-E), respectively. EPA or DHA levels in
phospholipids increased with increasing quantities of die-
tary EPA-E or DHA-E, respectively, but the total phosphol-
ipid n3 levels were highest in animals to which the lowest
dose of EPA-E or DHA-E was administered. Furthermore,
Venkatraman et al. [28] investigated the existence of a die-
tary maximum level for incorporation of n3 fatty acids
into membrane phospholipids of weanling rats. In this
study, animals were fed a diet which provided increasing
amounts of C20 and C22 n3 fatty acids such as C20:5-n3
and C22:6-n3, and after 4 weeks of feeding, the fatty acid
composition of membrane phospholipids of liver nuclear
envelopes was analyzed. An increase in n3 dietary fatty
acid administration from 1.1% to 5% of total fatty acids
resulted in an increase in 20:5-n3 membrane phospholi-
pid content. But further rise of dietary n3 fatty acids did
not lead to an increased incorporation of 20:5-n3 into
membrane phospholipids.
Conversion of [13C]LA and [13C]ALA to their longer chain 
homologues
In addition to the incorporation, the administered fatty
acids have also been converted to their longer chain
homologues, as we could clearly demonstrate by using
labeled [13C]LA and [13C]ALA. As well as rates of incorpo-
ration, the extent of conversion was affected by the ratio
of administered fatty acids. Regarding the conversion of
[13C]18:2-n6 to 20:4-n6, it was remarkable that the
amount of AA formed was significantly lower in cells
exposed to 100 μM [13C]LA than in cells which were incu-Nutrition & Metabolism 2009, 6:8 http://www.nutritionandmetabolism.com/content/6/1/8
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Kinetics experiments – relative mRNA levels of D5D, D6D, PPARα, SREBP-1c, MEKK1 and MEK1 after 24 hrs exposure of  HEPG2 cells to ALA-methylester, relating to non-exposed control cells (mRNA levels set as 1) Figure 2
Kinetics experiments – relative mRNA levels of D5D, D6D, PPARα, SREBP-1c, MEKK1 and MEK1 after 24 hrs 
exposure of HEPG2 cells to ALA-methylester, relating to non-exposed control cells (mRNA levels set as 1). 
Data are expressed as mean ± SEM. Asterisks indicate a significant difference of the values compared to control cells (*: p ≤ 
0.05 **: p ≤ 0.01, ***: p ≤ 0.001).Nutrition & Metabolism 2009, 6:8 http://www.nutritionandmetabolism.com/content/6/1/8
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bated with mixtures of [13C]LA and [13C]ALA. However,
when comparing the percentage rates of conversion of
[13C]LA and [13C]ALA to AA and EPA/DHA, respectively,
the conversion of [13C]ALA to EPA/DHA was higher than
the conversion of [13C]LA to AA. This effect might be
attributed to a differential effect of fatty acids of the n6
series and the n3 series on desaturase activity and/or gene
expression. Since suppression of D5D and D6D activities
by dietary unsaturated fatty acids was shown to be associ-
ated with decreased D5D and D6D mRNA levels [29,30],
we investigated whether these transcript levels were
altered after 6 hrs of incubating the HepG2 cells with
either LA and ALA or mixtures of both fatty acids.
Interestingly, exposure of HepG2 cells to 100 μM LA
caused a marked (p < 0.001) increase of the transcript
level of the D6D gene, whereas the exposure to 100 μM
ALA did not alter the transcript levels of the D6D gene. In
contrast, mRNA level of the gene encoding for D5D was
significantly (p < 0.001) decreased only by exposure to
100 μM of pure LA, relating to non-exposed control cells.
Administration of LA alone or as part of the mixture led to
a strong decrease of the transcript level of the D5D gene,
relating to non-exposed cells. Since both, Δ6- and Δ5-
desaturation reactions, were shown to be rate-limiting for
conversion of LA or ALA to their longer chain homo-
logues, we assume that formation of 20:4-n6 in cells incu-
bated with 100 μM LA was limited by reduced D5D gene
expression.
Despite of high amounts of EPA formed in cells exposed
to 100 μM [13C]ALA, conversion to DHA was significantly
(p < 0.001) lower in those cells compared to cells incu-
bated with lower doses of [13C]ALA in the form of
[13C]LA/[13C]ALA mixtures.
Similar results regarding the conversion of EPA to DHA
were described by Robinson et al. [27]. After feeding diets
containing 3%, 6% or 10% of EPA ethyl ester (EPA-E) to
female mice there were no increases in spleen phospholi-
Dose response experiments – relative mRNA levels of D5D, D6D, PPARα, SREBP-1c, MEKK1 and MEK1 after exposure of  HEPG2 cells to LA-/ALA-methylester at ratios of 0:1, 1:0, 1:1 and 4:1, relating to non-exposed control cells (mRNA levels set  as 1) Figure 3
Dose response experiments – relative mRNA levels of D5D, D6D, PPARα, SREBP-1c, MEKK1 and MEK1 after 
exposure of HEPG2 cells to LA-/ALA-methylester at ratios of 0:1, 1:0, 1:1 and 4:1, relating to non-exposed con-
trol cells (mRNA levels set as 1). Data are expressed as mean ± SEM. Asterisks indicate a significant difference of the val-
ues compared to control cells (**: p ≤ 0.01, ***: p ≤ 0.001).Nutrition & Metabolism 2009, 6:8 http://www.nutritionandmetabolism.com/content/6/1/8
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pid DHA levels in animals fed either the 10% or the 6%
EPA-E diet. Only administration of the 3% EPA-E diet was
associated with an elevation of DHA levels in phospholi-
pids. According to these findings, we assume that admin-
istration of n3 PUFAs beyond a certain level suppresses
formation of DHA from EPA. However, the general extent
of conversion from ALA to EPA and DHA in men was
reported to be about 8% for EPA and less than 0.05% for
DHA [6]. The conversion rates in our experiments were
about 16% for EPA and about 0.7% for DHA, after incu-
bation of the cells with an [13C]LA/[13C]ALA mixture of
1:1. This result gives rise to the possibility of shifting the
conversion of ALA to EPA and DHA to higher rates by
adjustment of the ratio of n6/n3 fatty acids.
Partitioning of LA and ALA towards  -oxidation
Since the total recovery (calculated by addition of total
cellular recovery and recovery within cell culture
medium) of the administered fatty acids was below 100%,
it seems likely that oxidation of LA and ALA also took
place since both fatty acids are known to be substrates for
β-oxidation. This hypothesis of partial degradation of
[13C]LA and [13C]ALA via β-oxidation in our experiments
is supported by results by a study of Mayes et al. [20], who
administered [13C] labeled ALA to preterm infants.
Appearance of 13CO2 in breath, which was determined as
a marker of ALA partitioning towards β-oxidation, ranged
from 7.6 to 19%. In our experiments, the amount of non-
recovered [13C]ALA or [13C]LA ranged between 3 and
14%, respectively. Therefore, we assume that this portion
of [13C]ALA or [13C]LA was used for β-oxidation since, in
addition, molecular masses of non-enzymatically gener-
ated oxidation products were not detected by HRGC-CI/-
MS (data not shown).
Generally, genes of fatty acid oxidation are induced by the
peroxisome proliferators-activated receptor alpha
(PPARα). Furthermore, fatty acids such as alpha-linolenic
acid are considered natural ligands of PPARα because they
were shown to bind and activate PPARα in vitro [30].
The administration of 100 μM pure ALA alone effectuated
a marked induction of PPARα (p < 0.001) in our experi-
ments. Also, total recovery of [13C]ALA in cells exposed to
pure [13C]ALA was considerably lower, compared to cells
incubated with any of the mixtures of [13C]LA and
[13C]ALA. Hence, we presume that [13C]ALA was preferen-
tially used as substrate for PPARα-mediated β-oxidation
in cells incubated with pure [13C]ALA. However, the
amount of 13CO2 was not analyzed in this experiment.
Effect of LA and ALA on lipogenesis
The transcription factor SREBP-1c plays a pivotal role in
the dietary regulation of most hepatic lipogenic genes
[31], including the expression of D5D and D6D [13] and
its primary role is assumed to be the regulation of highly
polyunsaturated fatty (PUFA) acid supply for membrane
phospholipids [32]. Expression of SREBP-1c genes was
shown to be down-regulated by dietary PUFA [33]. In con-
trast to this, the here presented results demonstrate that,
after 3 hrs of exposure time, the transcript level of SREBP-
1c gene was significantly (p < 0.001) induced by exposi-
tion of HepG2 cells to LA or ALA at a concentration of 100
μM and the mixture of LA and ALA at a ratio of 1:1, respec-
tively. This result may imply a dose and time dependent
SREBP-1c gene regulation which has to be proven in
future studies.
Besides SREBP-1c, peroxisome proliferators such as alpha-
linolenic acid paradoxically are identified as activators of
D6D and probably D5D gene transcription [11-13]. He et
al. [12] hypothesized hat this up-regulation of gene tran-
scription might be a compensatory response to increased
demand in PUFAs caused by induction of fatty acid oxida-
tion.
An intracellular activation of the mitogen-activated
(MAP) kinase cascade by ectopic expression of these
upstream activators had a direct stimulatory effect on the
transcriptional activity of SREBP-1c via phosphorylation
of MAP kinases ERK1 and ERK2 [34]. Hence, PPARα is
also reported as a substrate for several kinases such as
ERK1 and ERK2 [14,35], in addition to ligand-induced
regulation, transcriptional activity of PPARα may increase
via phosphorylation of certain domains of the receptor
protein [36]. In this work, the transcript levels of the
MEKK1 and MEK1 genes were markedly (p < 0.001)
increased after the cells' exposure to LA, ALA or mixtures
of both. In clear contrast to the transcript level of MEKK1
gene, the transcript levels of the MEK1 gene were lower,
the higher the LA-content in the mixture was. However,
we did not measure an activation of the transcriptional
activities of either PPARα or SREBP-1c via MAP kinase
phosphorylation. But the enhanced transcript level could
indicate an induction of the respective pathway, which
may has led to the observed induction of D6D and D5D.
Further investigations with regard to receptor-ligand-
binding and state of phosphorylation of PPARα or SREBP-
1c receptor proteins in the presence of defined ration of
n6/n3 PUFAs are necessary to elucidate the mechanisms
of gene expression.
Conclusion
Our investigations show that exposure of human hepato-
cytes to different mixtures of LA and ALA affected tran-
script levels of a portfolio of genes encoding regulating
proteins involved in several stages of fatty acid metabo-
lism. This effect strongly depends on the ratio of n6/n3
fatty acids, indicating the importance of ingesting an
appropriate amount of fatty acids, but also an appropriateNutrition & Metabolism 2009, 6:8 http://www.nutritionandmetabolism.com/content/6/1/8
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ratio of n6 and n3 fatty acids. This is further confirmed by
the fact that maximum conversion of LA to AA was meas-
ured only in the presence of ALA. Omitting ALA seems to
result in higher oxidation rates as indicated by high tran-
script levels of PPARα. Additionally, the n6/n3 ratio
strongly influenced the elongation of ALA to EPA and
DHA as well as the transcript levels of D5D and D6D.
However, from a nutritional perspective, our findings sug-
gest that a diet-induced enhancement of the cell mem-
brane content of highly unsaturated fatty acids is only
possible up to a certain level. Increasing the administered
quantity of labeled alpha-linolenic acid resulted in a
reduced effectiveness of [13C]ALA incorporation. Percent-
age incorporation of [13C]ALA was maximal after expo-
sure of [13C]LA/[13C]ALA at a ratio of 4:1 to HepG2 cells.
With regard to the elongation of ALA to EPA and DHA,
our results clearly indicate the efficiency of altering the
dietary ratio of LA to ALA in favor of ALA by increasing the
concentration of n3 fatty acids in human hepatocytes. At
this, administration of LA/ALA at a ratio of 1:1 led to the
highest formation of LCPUFAs of the n3 series.
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